-
PREOPERATIVE USE OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS)AND SHORT-TERM POSTOPERATIVE OUTCOMES AFTER BARIATRIC SURGERY: A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:41 PM -
THE ECONOMIC IMPACT OF METABOLIC SYNDROME IN SCHIZOPHRENIA: A CLAIMS-BASED ANALYSIS IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
THE DIABETES PENALTY, ARE WE COMPARING LIKE VERSUS LIKE IN OBESITY MANAGEMENT? RE-RANKING SEMAGLUTIDE AND TIRZEPATIDE AFTER ADJUSTING FOR COMORBID T2D CONFOUNDING
Feb 25, 2026, 14:41 PM -
COST-SAVING OUTCOMES FROM THE IDENTIFICATION AND MANAGEMENT OF PHARMACOLOGICAL INEFFICIENCIES IN PATIENTS WITH CHRONIC DISEASES
Feb 25, 2026, 14:41 PM -
BAYESIAN MULTI-PARAMETER EVIDENCE SYNTHESIS FOR INFORMED EXTRAPOLATIONS OF TIME-TO-EVENT OUTCOMES IN MULTISTATE MODELS
Feb 25, 2026, 14:41 PM -
EVALUATION AND VALIDATION OF A NOVEL POISON SEVERITY AND MORTALITY SCALE: A PILOT STUDY
Feb 25, 2026, 14:41 PM -
A MARKOV COHORT MODEL EVALUATING THE COST-EFFECTIVENESS OF ASCIMINIB VERSUS STANDARD TYROSINE KINASE INHIBITORS IN THIRD-LINE CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA: A FIVE-YEAR ANALYSIS FROM THE PAYER PERSPECTIVE
Feb 25, 2026, 14:41 PM -
MULTILEVEL SOCIOECONOMIC AND REGIONAL DISPARITIES IN MATERNAL HEALTHCARE ACCESS IN A HIGH-BURDEN SETTING
Feb 25, 2026, 14:41 PM -
IMPACT OF TIME-VARYING RELAPSE RISK ON LONG-TERM COST-EFFECTIVENESS OUTCOMES IN CHRONIC RELAPSING DISEASES
Feb 25, 2026, 14:41 PM -
SOCIETAL ECONOMIC BURDEN AND TREATMENT VALUE OF HEMOPHILIA A IN MOROCCO: AN EXPLORATORY PILOT STUDY USING HUMAN CAPITAL AND INPUT-OUTPUT ANALYSIS
Feb 25, 2026, 14:41 PM -
CHARACTERIZATION OF PATIENTS WITH PROSTATE CANCER IN COLOMBIA FROM A REAL-WORLD MULTICENTER FROM A HEALTHCARE RESOURCE UTILIZATION (HRU) STUDY
Feb 25, 2026, 14:41 PM -
A REAL-WORLD EVIDENCE STUDY OF EPIGENOMIC SUBTYPING IN LIQUID BIOPSY-BASED LUNG CANCER COHORTS
Feb 25, 2026, 14:41 PM -
THE SAFETY AND EFFECTIVENESS OF STERILE HYPOCHLOROUS ACID USED AS SURGICAL IRRIGATION SOLUTION TO REDUCE POSTOPERATIVE COMPLICATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Feb 25, 2026, 14:41 PM -
DEVELOPMENT AND EVALUATION OF ERADICATION EFFICIENCY OF NOVEL GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR THE TREATMENT OF H. PYLORIINFECTION
Feb 25, 2026, 14:41 PM -
REAL-WORLD DATA IN ORPHAN DRUG APPROVALS: A COMPARATIVE ANALYSIS OF THE UNITED STATES, CHINA, AND JAPAN
Feb 25, 2026, 14:41 PM -
DIRECT ORAL ANTICOAGULANTS IN BRAZIL: PRICE TRENDS, MARKET COMPETITION, AND POLICY IMPLICATIONS
Feb 25, 2026, 14:41 PM -
INCREASED HEALTHCARE COSTS AND RESOURCE UTILIZATION FOLLOWING PROGRESSION IN PATIENTS WITH HR+/HER2- METASTATIC BREAST CANCER RECEIVING CHEMOTHERAPY
Feb 25, 2026, 14:41 PM -
COMPARATIVE EFFECTIVENESS OF ALPHA BLOCKERS VERSUS ALPHA INHIBITORS USING PATIENT-REPORTED OUTCOMES AMONG ADULT MEN DIAGNOSED WITH BPH IN THE USA USING MEPS DATA (2018-2023)
Feb 25, 2026, 14:41 PM -
COVERAGE COMPLETENESS AND TREATMENT COST ESTIMATION FOR ADMINISTERED DRUGS IN US COMMERCIAL PAYER PRICE TRANSPARENCY DATA
Feb 25, 2026, 14:41 PM -
HOW IMPROVING SCHOOL-AGED CHILDREN’S HEALTH CAN SIMULTANEOUSLY REDUCE INEQUALITY IN BOTH HEALTH AND WEALTH
Feb 25, 2026, 14:41 PM
